These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32881288)

  • 1. Collateral damage of a global pandemic: implications of COVID-19 for Australians with cardiovascular disease.
    Murphy AC; Koshy AN; Yudi MB
    Intern Med J; 2020 Aug; 50(8):1020-1021. PubMed ID: 32881288
    [No Abstract]   [Full Text] [Related]  

  • 2. Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia.
    Adikari DH; Kushwaha VV; Jepson NS
    Heart Lung Circ; 2020 Aug; 29(8):1109-1111. PubMed ID: 32653299
    [No Abstract]   [Full Text] [Related]  

  • 3. How is the cardiovascular patient managed during Covid-19 pandemic? A report from the frontline.
    Cortese B
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):E565. PubMed ID: 32433798
    [No Abstract]   [Full Text] [Related]  

  • 4. CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.
    Linschoten M; Asselbergs FW
    Eur Heart J; 2020 May; 41(19):1795-1796. PubMed ID: 32267494
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial commentary: Hitting a moving target: The challenge of creating consensus treatment protocols for cardiovascular care during the coronavirus pandemic.
    Yang E; Marine JE
    Trends Cardiovasc Med; 2020 Aug; 30(6):326-327. PubMed ID: 32562772
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.
    Krittanawong C; Virk HUH; Narasimhan B; Wang Z; Narasimhan H; Zhang HJ; Sun T; Messerli FH
    Prog Cardiovasc Dis; 2020; 63(4):527-528. PubMed ID: 32389584
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
    Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility and prognosis of COVID-19 patients with cardiovascular disease.
    Wang BX
    Open Heart; 2020 Jun; 7(1):. PubMed ID: 32587104
    [No Abstract]   [Full Text] [Related]  

  • 9. SCAI initiatives during the COVID-19 pandemic.
    Mahmud E
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):995-996. PubMed ID: 32562454
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular diseases, lipid-lowering therapies and European registries in the COVID-19 pandemic.
    Morawietz H; Julius U; Bornstein SR
    Cardiovasc Res; 2020 Aug; 116(10):e122-e125. PubMed ID: 32678443
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic.
    Duffy EY; Cainzos-Achirica M; Michos ED
    Circulation; 2020 Jun; 141(24):1943-1945. PubMed ID: 32310675
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical care capacity during the COVID-19 pandemic: Global availability of intensive care beds.
    Ma X; Vervoort D
    J Crit Care; 2020 Aug; 58():96-97. PubMed ID: 32408107
    [No Abstract]   [Full Text] [Related]  

  • 13. The Role of the American Heart Association in the Global COVID-19 Pandemic.
    Elkind MSV; Harrington RA; Benjamin IJ
    Circulation; 2020 Apr; 141(15):e743-e745. PubMed ID: 32181680
    [No Abstract]   [Full Text] [Related]  

  • 14. Priority plan for invasive cardiac electrophysiology procedures during the coronavirus disease 2019 (COVID-19) pandemic.
    Wang NC; Jain SK; Estes NAM; Barrington WW; Bazaz R; Bhonsale A; Kancharla K; Shalaby AA; Voigt AH; Saba S
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1255-1258. PubMed ID: 32323382
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 and the Heart.
    Rojulpote C; Gonuguntla K; Patil S; Bhattaru A; Bravo PE
    Colomb Med (Cali); 2020 Jun; 51(2):e4320. PubMed ID: 33012891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.
    Chatterjee NA; Cheng RK
    Heart; 2020 Aug; 106(15):1119-1121. PubMed ID: 32451360
    [No Abstract]   [Full Text] [Related]  

  • 17. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.
    Yang C; Jin Z
    JAMA Cardiol; 2020 Jul; 5(7):743-744. PubMed ID: 32211809
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.
    Bonow RO; Fonarow GC; O'Gara PT; Yancy CW
    JAMA Cardiol; 2020 Jul; 5(7):751-753. PubMed ID: 32219362
    [No Abstract]   [Full Text] [Related]  

  • 19. Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?
    Chibabhai V; Duse AG; Perovic O; Richards GA
    S Afr Med J; 2020 Jun; 110(7):572-573. PubMed ID: 32880323
    [No Abstract]   [Full Text] [Related]  

  • 20. Collateral Damage During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Gilligan J; Gologorsky Y
    World Neurosurg; 2020 Aug; 140():413-414. PubMed ID: 32419877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.